A phase I trial of lapatinib in combination with carboplatin in patients with platinum sensitive recurrent epithelial ovarian cancer

被引：0
|
作者：
Kimball, K. J. [1 ]
Numnum, T. M. [1 ]
Estes, J. M. [1 ]
Kirby, T. O. [1 ]
Barnes, M. N. [1 ]
Alvarez, R. D. [1 ]
机构：
[1] UAB, Birmingham, AL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14106
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] A phase I study of lapatinib in combination with carboplatin in women with platinum sensitive recurrent ovarian carcinoma
    Kimball, Kristopher J.
    Numnum, T. Michael
    Kirby, Tyler O.
    Zamboni, William C.
    Estes, Jacob M.
    Barnes, Mack N.
    Matei, Daniela E.
    Koch, Kevin M.
    Alvarez, Ronald D.
    GYNECOLOGIC ONCOLOGY, 2008, 111 (01) : 95 - 101
  • [2] A phase I study of lapatinib in combination with carboplatin in women with recurrent platinum-sensitive ovarian carcinoma
    Kimball, K. J.
    Numnum, T. M.
    Kirby, T. O.
    Zamboni, W. C.
    Estes, J. M.
    Barnes, M. N.
    Matei, D.
    Alvarez, R. D.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S60 - S60
  • [3] Phase I study of combination of vorinostat, carboplatin, and gemcitabine in women with recurrent, platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal cancer
    Matulonis, Ursula
    Berlin, Suzanne
    Lee, Hang
    Whalen, Christin
    Obermayer, Elizabeth
    Penson, Richard
    Liu, Joyce
    Campos, Susana
    Krasner, Carolyn
    Horowitz, Neil
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (02) : 417 - 423
  • [4] Phase I study of combination of vorinostat, carboplatin, and gemcitabine in women with recurrent, platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal cancer
    Ursula Matulonis
    Suzanne Berlin
    Hang Lee
    Christin Whalen
    Elizabeth Obermayer
    Richard Penson
    Joyce Liu
    Susana Campos
    Carolyn Krasner
    Neil Horowitz
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 417 - 423
  • [5] A phase I/II study of topotecan in combination with carboplatin in recurrent epithelial ovarian cancer
    Bolis, G
    Scarfone, G
    Sciatta, C
    Polverino, GP
    Rosa, C
    Guarnerio, P
    Parazzini, F
    GYNECOLOGIC ONCOLOGY, 2001, 83 (03) : 477 - 480
  • [6] Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer
    Anita Schwandt
    Vivian E. von Gruenigen
    Robert M. Wenham
    Heidi Frasure
    Susan Eaton
    Nancy Fusco
    Pingfu Fu
    John J. Wright
    Afshin Dowlati
    Steven Waggoner
    Investigational New Drugs, 2014, 32 : 729 - 738
  • [7] Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer
    Schwandt, Anita
    von Gruenigen, Vivian E.
    Wenham, Robert M.
    Frasure, Heidi
    Eaton, Susan
    Fusco, Nancy
    Fu, Pingfu
    Wright, John J.
    Dowlati, Afshin
    Waggoner, Steven
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (04) : 729 - 738
  • [8] Combination carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer
    Horowitz, N. S.
    Penson, R. T.
    Campos, S. M.
    Lee, J.
    Kendall, D. L.
    Krasner, C. N.
    Berlin, S. T.
    Roche, M.
    Duska, L. R.
    Matulonis, U. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] A Phase 1 and Pharmacodynamic Study of Decitabine in Combination With Carboplatin in Patients With Recurrent, Platinum-Resistant, Epithelial Ovarian Cancer
    Fang, Fang
    Balch, Curt
    Schilder, Jeanne
    Breen, Timothy
    Zhang, Shu
    Shen, Changyu
    Li, Lang
    Kulesavage, Carol
    Snyder, Anthony J.
    Nephew, Kenneth P.
    Matei, Daniela E.
    CANCER, 2010, 116 (17) : 4043 - 4053
  • [10] The combination of gemcitabine and carboplatin shows similar efficacy in the treatment of platinum-resistant and platinum-sensitive recurrent epithelial ovarian cancer patients
    Safra, Tamar
    Asna, Noam
    Veizman, Anat
    Shpigel, Shulem
    Matcejevsky, Dianna
    Inbar, Moshe
    Grisaru, Dan
    ANTI-CANCER DRUGS, 2014, 25 (03) : 340 - 345
12345